Literature DB >> 3341017

Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.

J R Regueiro1, A Arnaiz-Villena.   

Abstract

C4 allotype frequencies and their combination with factor B and C2 alleles (complotypes) were studied in a sample of the Spanish population in relation to MHC class I, class II and GLO alleles. The shorter genetic distances found for C4 between Spaniards and North Africans and the high frequency of extended HLA haplotypes (GLO 2) HLA-DR3 F1C30 HLA-B18 HLA-Cw5 (HLA-A30) and HLA-DR7 S1C21 HLA-Bw50 HLA-Cw6 are consistent with a paleo-North African ethnic origin (about 20,000 years B.C.) of a part of present Spaniards (Iberians), and with the effect of racial admixture during late Moslem invasions (from the 8th to the 15th century). The complotype null alleles C4A QO and C4B QO may be under natural selection pressure when found in cis position, since they are never in the same haplotype in families. The underestimation of these C4 null alleles' frequencies in unrelated individuals as compared to genotyped families is shown to be a very likely event and a serious hindrance for C4-disease association studies. We have not found any C4 duplications in the Spanish population; this may be due to sample size limitations or to the degree of admixture of our population. Strikingly, no positive linkage disequilibrium between C4A and C4B alleles is detected in unrelated individuals nor in families, although strong associations are maintained among Bf, C2, C4, HLA-A, HLA-B, HLA-C and HLA-DR markers. Assuming that all MHC polymorphisms have reached equilibrium, several explanations are proposed, including the possibility of no, different or additional natural selection mechanisms operating on some MHC class III genes (Bf, C2, C4 alleles combinations for most appropriate C3 convertases), as compared to those affecting class I and class II gene clusters (most advantageous immune response genes sets).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341017     DOI: 10.1111/j.1399-0039.1988.tb02060.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Genetic structure of the novel low-frequency haplotype HLA-B49, SC01, DR4 and its contribution to insulin-dependent diabetes susceptibility.

Authors:  O G Segurado; P Iglesias-Casarrubios; P Morales; J Martínez-Laso; J Partanen; R D Campbell; A Arnaiz-Villena
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Complement C4 types in coeliacs and controls.

Authors:  J Cahill; F M Stevens; C F McCarthy
Journal:  Ir J Med Sci       Date:  1991-06       Impact factor: 1.568

3.  The "Sardinian" HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication?

Authors:  L Contu; C Carcassi; J Dausset
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  A decrease in the estimated frequency of the extended HLA haplotype B18 CF130 DR3 DQw2 is common to non-insulin-dependent diabetes, juvenile rheumatoid arthritis, and Berger's disease.

Authors:  J R Regueiro; A Arnaiz-Villena; J L Vicario; J Martinez-Laso; A Pacheco; J M Rivera-Guzman
Journal:  Experientia       Date:  1993-07-05

5.  Three new HLA-G alleles and their linkage disequilibria with HLA-A.

Authors:  P Morales; A Corell; J Martínez-Laso; J M Martín-Villa; P Varela; E Paz-Artal; L M Allende; A Arnaiz-Villena
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility.

Authors:  D De Juan; J M Martín-Villa; J J Gómez-Reino; J L Vicario; A Corell; J Martínez-Laso; D Benmammar; A Arnaiz-Villena
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

7.  Interleukin 2 production in a family with systemic lupus erythematosus and a C4Q0 heterozygous inheritance.

Authors:  C Gutierrez; E Cabrero; J L Vicario; M Martín Villa; M A Rengel; F J Gomez Campdera; M Yebra; E Fernández-Cruz; A Arnaiz Villena
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

8.  Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE).

Authors:  O G Segurado; A A Arnaiz-Villena; P Iglesias-Casarrubios; J Martinez-Laso; J L Vicario; G Fontan; M Lopez-Trascasa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.